EC Paediatrics

Since ancient times, people have utilized plants for therapeutic purposes. Over the past 20 years, there has been a noticeable increase in the use of medicinal plants. Due to their natural origin, people believe herbal products to be safe, but they fail to consider whether these plants have any toxic properties. This is a significant health issue. The purpose of this review is to highlight various contributions and the importance of medicinal plants that are toxic to both humans and animals. Information on the toxicological characteristics of medicinal plants and their possible impacts on both humans and animals is the goal of this review. The primary toxic medicinal plant effects on humans and animals, or those that lead to emergency medical visits, are reviewed in this article. To determine the previously documented toxicity to humans and animals, articles discussing the "medicinal plants effect in humans and animals" were found in online databases. According to the primary toxic effects of medicinal plants, the report in the current review was taken from our prepared database. According to our findings, the effects of medicinal plants that are toxic to humans and animals are reviewed in this work. To provide information regarding the safe use of the medicinal plants mentioned in this review, more toxicological research is required.

 Keywords: Medicinal Plants; Toxicity; Neurotoxicity; Reproduction; Humans and Animals

1. Thomas B and Rajendran A. “Less known ethnomedicinal plants used by Kurichar tribe of Wayanad district, Southern Western Ghats Kerala, India”. Botany Research International 2 (2013): 32-35.
2. Mendieta MC., et al. “Toxic plants: importance of knowledge for realization of health education”. Journal of Nursing UFPE on Line3 (2014): 680-686.
3. Pan SY., et al. “Historical perspective of traditional indigenous medical practices: The current renaissance and conservation of herbal resources”. Evidence Based Complementary and Alternative Medicine (2014): 525340.
4. Tucakov J. “Pharmacognosy”. Beograd: Institute for Text Book Issuing in SR, Srbije (1964): 11-30.
5. WHO, IUCN, & WWF. “Guidelines on the conservation of medicinal plants”. Gland, Switzerland (1993): 38.
6. Rozin P., et al. “Preference for natural: Instrumental and ideational/moral motivations, and the contrast between foods and medicines”. Appetite2 (2004): 147-154.
7. Quideau SP., et al. “Plant polyphenols: chemical properties, biological activities, and synthesis”. Angewandte Chemie International Edition3 (2011): 586-621.
8. Kittakoop P., et al. “Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation”. Current Topics in Medicinal Chemistry2 (2014): 239-252.
9. Awuchi CG. “Medicinal plants: the medical, food, and nutritional biochemistry and uses”. International Journal of Advanced Academic Research11 (2019): 220-241.
10. Maciel MAM., et al. “Medicinal plants: the need for multidisciplinary scientific studies”. Química Nova3 (2002): 429-438.
11. Cowan MM. “Plant products as antimicrobial agents”. Clinical Microbiology Reviews4 (1999): 564-582.
12. Aguilar-Contreras A and Zollas C. “Plantas t´oxicas de M´exico”. Instituto Mexicano del Seguro Social, Mexico city, Mexico (1982).
13. Jamshidi-Kia F., et al. “Medicinal plants: past history and future perspective”. Journal of Herbmed Pharmacology1 (2018): 1-7.
14. World Health Organization (WHO). “WHO Traditional Medicine Strategy: 2014-2023”. World Health Organization (WHO) (2013): 1-76.
15. So O., et al. “Medicinal plants and sustainable human health: a review”. Horticulture International Journal4 (2018): 194-195.
16. Rao SR and Ravishankar GA. “Plant cell cultures: Chemical factories of secondary metabolites”. Biotechnology Advances 2 (2002): 101-153.
17. Baker DD., et al. “The value of natural products to future pharmaceutical discovery”. Natural Product Reports6 (2007): 1225-1244.
18. Efferth T. “Biotechnology applications of plant callus cultures”. Engineering 1 (2019): 50-59.
19. Shedoeva A., et al. “Wound healing and the use of medicinal plants”. Evidence-Based Complementary and Alternative Medicine (2019): 2684108.
20. Yuan H., et al. “The traditional medicine and modern medicine from natural products”. Molecules5 (2016): 559.
21. Wangchuk P. “Therapeutic applications of natural products in herbal medicines, biodiscovery programs, and biomedicine”. Journal of Biologically Active Products from Nature1 (2018): 1-20.
22. Pastorino G., et al. “Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review”. Phytotherapy Research12 (2018): 2323-2339.
23. Bavunoglu I., et al. “Oleander poisoning as an example of self-medication attempt”. Balkan Medical Journal5 (2016): 559-562.
24. Moloudizargari M., et al. “Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids”. Pharmacognosy Reviews14 (2013): 199-212.
25. Knolker HJ. “The Alkaloids. Academic Press”. 1^st Edition 246 (77) (2017).
26. Builders P. “Herbal Medicine”. BoD-Books on Demand (2019).
27. Khlifi D., et al. “Composition and anti-oxidant., anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis and Peganum harmala L”. Food and Chemical Toxicology 55 (2013): 202-208.
28. Asgarpanah J and Ramezanloo F. “Chemistry, pharmacology and medicinal properties of Peganum harmala L”. African Journal of Pharmacy and Pharmacology22 (2012): 1573-1580.
29. Niroumand MC., et al. “Medicinal properties of Peganum harmala in traditional Iranian medicine and modern phytotherapy: A review”. Journal of Traditional Chinese Medicine 35.1 (2015): 104-109.
30. Mahmoudian M., et al. “Toxicity of Peganum harmala: Review and a Case Report”. Iranian Journal of Pharmacology and Therapeutics1 (2002): 1-4.
31. Nasri H and Shirzad H. “Toxicity and safety of medicinal plants”. Journal of Herbmed Pharmacology2 (2013): 21-22.
32. Kuete V. “Toxicological Survey of African Medicinal Plants”. 1^st In: Kuete V., editor. London: Elsevier Inc (2014): 1-742.
33. Fennell CW., et al. “Assessing African medicinal plants for efficacy and safety: Agricultural and storage practices”. Journal of Ethnopharmacology2-3 (2004): 113-121.
34. Sharma OP., et al. “Review of the hepatotoxic plant Lantana camara”. Critical Reviews in Toxicology4 (2007): 313-352.
35. Komlaga G., et al. “Medicinal plants and finished marketed herbal products used in the treatment of malaria in the Ashanti region, Ghana”. Journal of Ethnopharmacology 172 (2015): 333-346.
36. Raman A and Lau C. “Anti-diabetic properties and phytochemistry of Momordica charantia (Cucurbitaceae)”. Phytomedicine 2.4 (1996): 349-362.
37. OECD, OECD Guideline for Testing of Chemicals: Acute Eye Irritation/Corrosion (No: 405), Section 4, OECD Publishing (2012): 1-19.
38. OECD, OECD Guideline for Testing of Chemicals: Skin Sensitisation (No. 406), Section 4, OECD Publishing (1992): 1-9.
39. Magnusson B and Kligman AM. “The identification of contact allergens by animal assay. The Guinea pig maximization test”. Journal of Investigative Dermatology3 (1969): 268-276.
40. OECD, OECD Guideline for Testing of Chemicals: Prenatal Developmental Toxicity Study (No. 414), Section 4, OECD Publishing (2001): 1-11.
41. OECD, OECD Guideline for Testing of Chemicals: Neurotoxicity Study in Rodents (No. 424), Section 4, OECD Publishing (1997): 1-15.
42. OECD, OECD Guideline for Testing of Chemicals, Section 4., Carcinogenicity Studies (No. 451), Section 4, OECD Publishing (2009): 1-15.
43. OECD, OECD Guideline for Testing of Chemicals: One-generation Reproduction Toxicity Study (No. 415), Section 4, OECD Publishing (1983): 1-8.
44. OECD, OECD Guideline for Testing of Chemicals: Two e Generation Reproduction Toxicity Study (No. 416), Section 4, OECD Publishing (2001): 1-13.